Dec 4, 2025 07:17AM
Nov 6, 2025 07:30AM
Oct 15, 2025 04:08PM
Aug 11, 2025 06:40AM
Aug 7, 2025 07:30AM
Jul 1, 2025 06:24AM
May 12, 2025 04:05PM Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Mar 18, 2025 06:39AM
Mar 6, 2025 04:01PM
Nov 5, 2024 08:00AM
Oct 9, 2024 07:21AM
Oct 7, 2024 04:01PM
Oct 7, 2024 04:01PM
Sep 24, 2024 06:48AM H.C. Wainwright Reiterates Buy Rating on Black Diamond Therapeutics (BDTX)
Sep 23, 2024 07:02AM
Sep 23, 2024 07:00AM
May 9, 2024 07:30AM
Apr 8, 2024 07:07AM
Mar 12, 2024 08:00AM
Jan 4, 2024 08:00AM
Nov 6, 2023 07:45AM Black Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Oct 14, 2023 12:30PM
Sep 18, 2023 07:00AM
Sep 18, 2023 07:00AM
Sep 11, 2023 08:00AM
Aug 11, 2023 07:30AM
Jun 27, 2023 08:13AM
Jun 27, 2023 07:00AM Black Diamond Therapeutics Announces Initial Dose Escalation Data Demonstrating Anti-Tumor Activity of BDTX-1535 in Non-Small Cell Lung Cancer Patients Across Multiple EGFR Mutation Families
May 9, 2023 07:30AM
Mar 9, 2023 07:30AM
Mar 9, 2023 07:30AM
Dec 19, 2022 08:05AM
Dec 19, 2022 08:00AM
Dec 19, 2022 08:00AM
Nov 8, 2022 08:00AM Black Diamond Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Nov 8, 2022 08:00AM
Oct 26, 2022 08:00AM
Oct 26, 2022 08:00AM
Oct 26, 2022 08:00AM
Aug 9, 2022 08:00AM
Aug 9, 2022 08:00AM
May 11, 2022 04:30PM Black Diamond Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 11, 2022 04:30PM
Mar 17, 2022 05:00PM
Mar 17, 2022 05:00PM
Jan 11, 2022 09:31AM
Jan 11, 2022 07:13AM
Jan 11, 2022 07:13AM
Jan 11, 2022 07:00AM Black Diamond Therapeutics Announces FDA Allowance of IND Application for BDTX-1535, A MasterKey Inhibitor of EGFR for the Treatment of Gliobastoma and Non-Small Cell Lung Cancer
Jan 11, 2022 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All